| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $559K | -98.7% |
| Cost of Revenue | $215K | -98.2% |
| Gross Profit | $344K | -98.9% |
| R&D Expense | $67.8M | -0.2% |
| SG&A Expense | $22.3M | -16.9% |
| Operating Income | -$91.1M | -43.8% |
| Pre-tax Income | -$88.6M | -99.3% |
| Income Tax | $11K | -98.7% |
| Net Income | -$88.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.3M | -90.7% |
| Short-term Investments | $73.8M | +183.9% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $118.7M | -36.7% |
| Total Assets | $131.4M | -35.1% |
| Current Liabilities | $13.6M | -19.1% |
| Total Liabilities | $69.1M | +0.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.3M | +7.9% |
| Capital Expenditures | $55K | -73.9% |
| Investing Cash Flow | -$48.0M | -118.5% |
| Financing Cash Flow | $15K | -100.0% |
| Free Cash Flow | -$62.3M | +8.1% |
| -95.6% |
| EPS (Basic) | -$0.63 | -90.9% |
| EPS (Diluted) | -$0.63 | -90.9% |
| Stockholders' Equity |
| $62.3M |
| -53.5% |